<DOC>
	<DOCNO>NCT02353949</DOCNO>
	<brief_summary>The study examine subject might indication Amyloid-PET accord Criteria define Amyloid Imaging Task Force . In subject impact Flutemetamol-Positron-Emission-Tomography -Scan ( PET ) clinical management disease course study 6 month .</brief_summary>
	<brief_title>Investigating Clinical Consequences Flutemetamol-PET-scanning</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<criteria>Dementia expert considers Amyloidscan appropriate accord Amyloidimaging task force criterion ( AIT ) counsel AmyloidPET expert 1 . Patients persistent progressive unexplained MCI 2 . Patients satisfy core clinical criterion possible AD unclear clinical presentation , either atypical clinical course etiologically mixed presentation 3 . Patients progressive dementia atypically early age onset ( 65 year less age ) 4. situation preamble AITCriteria fulfil Preambles AITCriteria fulfil 1 . A cognitive complaint objectively confirm impairment 2 . AD possible diagnosis , diagnosis uncertain comprehensive evaluation dementia expert 3 . When knowledge presence absence Abeta pathology expect increase diagnostic certainty alter management Diagnosis establish memory clinic experience physician dementia diagnostics The diagnostic procedure comprise minimum MRI , neuropsychology , routine blood test exclusion symptomatic cause MMSE &gt; 15 Competency consent Trial partner willing support study physician Written inform consent patient trial partner Understanding German language allow perform neuropsychological test Treating physician willing collaborate study team Evidence cognitive impairment mainly attribute another underlie medical condition ( e.g . medication , substance abuse , brain tumor , severe heart insufficiency , hepatic encephalopathy ) Clinically significant depression MRI exclusion criterion PET exclusion criterion 1 . Allergy Flutemetamol constituents 2 . History severe allergic reaction drug allergens 3 . Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Mild cognitive impairment</keyword>
	<keyword>Alzheimer</keyword>
	<keyword>PET</keyword>
	<keyword>Amyloid</keyword>
	<keyword>Frontotemporal</keyword>
</DOC>